Description

Veltuzumab is a humanized monoclonal antibody designed for targeted therapeutic applications. This compound is of significant interest in the biopharmaceutical sector for its specific binding properties and potential clinical utility. It is primarily utilized by research institutions and pharmaceutical developers engaged in oncology and immunology. The product, identified by CAS No. 728917-18-8, is supplied to meet the stringent demands of advanced therapeutic development.

Application

• Oncological Research: Investigation as a therapeutic agent for B-cell malignancies, including non-Hodgkin's lymphoma.
• Immunotherapy Development: Used in the research and development of novel antibody-based immunotherapies.
• Target Validation Studies: Serves as a critical tool for validating specific antigen targets in preclinical models.
• Bioconjugation & ADC Development: Acts as a base antibody for the creation of antibody-drug conjugates (ADCs).
• Diagnostic Reagent Production: Potential use in the development of in-vitro diagnostic assays and imaging agents.
• Mechanism of Action Studies: Employed in pharmacological studies to understand cell signaling and apoptosis pathways.

Basic Information

Product Name	Veltuzumab
CAS No.	728917-18-8
Molecular Formula	Contact for details
Molecular Weight	Approx. 150 kDa
Synonyms	hA20; IMMU-106; Anti-CD20 Monoclonal Antibody hA20; Humanized Anti-CD20 Antibody; Veltuzumab (USAN/INN); Monoclonal Antibody hA20; CD20-directed Monoclonal Antibody
EINECS	Contact for details

Quality Control

Our Veltuzumab is produced and tested under a rigorous quality management system. Each batch is characterized for identity, purity, potency, and stability to ensure it meets the high standards required for research and development purposes. Certificates of Analysis (COA) detailing specifications such as purity by SEC-HPLC, endotoxin levels, and biological activity are available upon request.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below. Avoid repeated freeze-thaw cycles. This product is hygroscopic (moisture-sensitive); ensure containers are sealed under controlled, dry conditions.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder or clear solution
Identification (HPLC/LC-MS)	Conforms to reference standard
Purity (SEC-HPLC)	≥ 95% (Monomer)
Protein Content (UV/A280)	As per COA
Endotoxin	< 1.0 EU/mg
Biological Activity (Binding)	Conforms to reference
pH	6.0 - 7.5 (for solution)

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.